RPGLF (Regent Pacific Group) Short Interest


RPGLF Regent Pacific Group Ltd RPGLF
7 GF Score
Price $0.01
! 7 Warning Signs
View Full Analysis

What is Regent Pacific Group Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

RPGLF vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regent Pacific Group's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regent Pacific Group Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Regent Pacific Group's Short Interest distribution charts can be found below:

* The bar in red indicates where Regent Pacific Group's Short Interest falls into.


RPGLF
7GF Score
Regent Pacific Group Ltd RPGLF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regent Pacific Group Business Description

Other Exchanges 00575:Hong KongRPG:Germany
Address 5 Queen\'s Road Central, 8th Floor, Henley Building, Hong Kong, HKG
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
7GF Score

Get the complete analysis for RPGLF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price